CARISMA Therapeutics (NASDAQ:CARM) Stock Quotes, Forecast and News Summary

Q: What sector and industry does CARISMA Therapeutics (CARM) operate in?

CARISMA Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CARISMA Therapeutics Stock (NASDAQ: CARM) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	248.00 / 143.94K
Day Range	- - -
52 Wk Range	0.80 - 3.16
Market Cap	$36.31M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	2.56%
Days to Cover	6.82

Recent News

This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Wednesday

Avi Kapoor

Why Are Carisma Therapeutics Shares Surging Friday?

Carisma Therapeutics Inc. (NASDAQ: CARM) shares are trading higher on Friday following the company's announcement of a significant development in its collaboration with Moderna.

Vaishali Prayag

Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	248.00 / 143.94K
Day Range	- - -
52 Wk Range	0.80 - 3.16
Market Cap	$36.31M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	2.56%
Days to Cover	6.82

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CARISMA Therapeutics (CARM) stock?

You can purchase shares of CARISMA Therapeutics (NASDAQ:CARM) through any online brokerage.

View our list of the best stock brokerages

Who are CARISMA Therapeutics (CARM) competitors?

Other companies in CARISMA Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Eterna Therapeutics (NASDAQ:ERNA), HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA) and Intensity Therapeutics (NASDAQ:INTS).

What is the forecast, or price target, for CARISMA Therapeutics (CARM) stock?

CARISMA Therapeutics has a consensus price target of $13.43.

What is the current price for CARISMA Therapeutics (CARM)?

The stock price for CARISMA Therapeutics (NASDAQ: CARM) is $0.8696 last updated November 21, 2024 at 6:20 AM EST.

Does CARISMA Therapeutics (CARM) pay a dividend?

There are no upcoming dividends for CARISMA Therapeutics.

When is CARISMA Therapeutics (NASDAQ:CARM) reporting earnings?

CARISMA Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is CARISMA Therapeutics (CARM) going to split?

There is no upcoming split for CARISMA Therapeutics.

What sector and industry does CARISMA Therapeutics (CARM) operate in?

CARISMA Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

CARISMA Therapeutics

CARISMA Therapeutics (CARM) Forecast